Overlap of myasthenia gravis, myocarditis, and inflammatory myopathy secondary to immune checkpoint inhibitor (pembrolizumab) on a background of previously undiagnosed thymoma-associated acetylcholine receptor antibody-positive myasthenia gravis
Immune checkpoint inhibitors have been used successfully over the last several years for treatment of many types of advanced cancer. Those agents cause uncontrolled activation of the immune system frequently resulting in immune-related adverse effects and exacerbation of pre-existing autoimmune dise...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2025-04-01
|
| Series: | Нервно-мышечные болезни |
| Subjects: | |
| Online Access: | https://nmb.abvpress.ru/jour/article/view/649 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|